NCT04083872View on ClinicalTrials.gov

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

October 21, 2019

Study Completion Date

November 1, 2019

Conditions
Cardiovascular Diseases
Interventions
DRUG

Reference drug

D744 Cap. 1 Cap., single oral administration under fasting condition

DRUG

Test drug

CKD-385 64 mg formulation I Tab. 1 Tab., single oral administration under fasting condition

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY